Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Pinto

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Endourology|November 29, 2024
Navigating Focal Therapy for Prostate Cancer: Contemporary Perspectives and Future Trajectories in the Canadian ContextCharles Hesswani, Pier-Paolo Avolio, Alexis Rompre-Brodeur, et al.
BJU International|April 3, 2012
Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus PanelMartijn Smeenge, Jelle Barentsz, David Cosgrove, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
<sup>18</sup>F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local TherapyEsther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, et al.
European Urology|October 5, 2014
Focal therapy: patients, interventions, and outcomes--a report from a consensus meetingIan A Donaldson, Roberto Alonzi, Dean Barratt, et al.
The Lancet. Infectious Diseases|July 21, 2015
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trialChristopher Koh, Laetitia Canini, Harel Dahari, et al.
Radiology|July 8, 2020
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRILiza Lindenberg, Esther Mena, Baris Turkbey, et al.
European Urology|June 29, 2016
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task ForceCaroline M Moore, Francesco Giganti, Peter Albertsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2017
Clinical impact of PSMA-based <sup>18</sup>F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapyEsther Mena, Maria L Lindenberg, Joanna H Shih, et al.
Journal for Immunotherapy of Cancer|June 23, 2025
Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancerWiem Lassoued, Ravi A Madan, Elisabetta Xue, et al.
European Urology|March 30, 2013
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working GroupCaroline M Moore, Veeru Kasivisvanathan, Scott Eggener, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Endourology|November 29, 2024
Navigating Focal Therapy for Prostate Cancer: Contemporary Perspectives and Future Trajectories in the Canadian ContextCharles Hesswani, Pier-Paolo Avolio, Alexis Rompre-Brodeur, et al.
BJU International|April 3, 2012
Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus PanelMartijn Smeenge, Jelle Barentsz, David Cosgrove, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
<sup>18</sup>F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local TherapyEsther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, et al.
European Urology|October 5, 2014
Focal therapy: patients, interventions, and outcomes--a report from a consensus meetingIan A Donaldson, Roberto Alonzi, Dean Barratt, et al.
The Lancet. Infectious Diseases|July 21, 2015
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trialChristopher Koh, Laetitia Canini, Harel Dahari, et al.
Radiology|July 8, 2020
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRILiza Lindenberg, Esther Mena, Baris Turkbey, et al.
European Urology|June 29, 2016
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task ForceCaroline M Moore, Francesco Giganti, Peter Albertsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2017
Clinical impact of PSMA-based <sup>18</sup>F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapyEsther Mena, Maria L Lindenberg, Joanna H Shih, et al.
Journal for Immunotherapy of Cancer|June 23, 2025
Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancerWiem Lassoued, Ravi A Madan, Elisabetta Xue, et al.
European Urology|March 30, 2013
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working GroupCaroline M Moore, Veeru Kasivisvanathan, Scott Eggener, et al.
Pageof 6